BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22219475)

  • 1. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM; Andreou C; Conrad CH; Colucci WS
    Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
    Missant C; Rex S; Segers P; Wouters PF
    Crit Care Med; 2007 Mar; 35(3):707-15. PubMed ID: 17255859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan.
    Müller S; How OJ; Jakobsen Ø; Hermansen SE; Røsner A; Stenberg TA; Myrmel T
    Circ Heart Fail; 2010 Mar; 3(2):277-85. PubMed ID: 20018954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
    Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.
    Leather HA; Ver Eycken K; Segers P; Herijgers P; Vandermeersch E; Wouters PF
    Crit Care Med; 2003 Sep; 31(9):2339-43. PubMed ID: 14501965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs.
    Masutani S; Cheng HJ; Hyttilä-Hopponen M; Levijoki J; Heikkilä A; Vuorela A; Little WC; Cheng CP
    J Pharmacol Exp Ther; 2008 Apr; 325(1):236-47. PubMed ID: 18174383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
    Pagel PS; Hettrick DA; Warltier DC
    Basic Res Cardiol; 1996; 91(4):296-307. PubMed ID: 8874779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
    Udvary E; Papp JG; Végh A
    Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
    Axelsson B; Johansson G; Abrahamsson P; Gupta A; Tydén H; Wouters P; Haney M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):719-28. PubMed ID: 23517167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
    Metzsch C; Liao Q; Steen S; Algotsson L
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
    Pagel PS; McGough MF; Hettrick DA; Lowe D; Tessmer JP; Jamali IN; Warltier DC
    J Cardiovasc Pharmacol; 1997 May; 29(5):563-73. PubMed ID: 9213196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
    Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
    Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of levosimendan in the early stages of endotoxemia.
    Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S
    Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart.
    Meyer K; Schipke JD; Klocke RC; Gams E; Korbmacher B
    Thorac Cardiovasc Surg; 2008 Oct; 56(7):379-85. PubMed ID: 18810693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.